South & Central America Prefilled Syringe Market Forecast to 2030 - Regional Analysis - by Type, Material, Design, Application, and Distribution Channel

The South & Central America prefilled syringe market was valued at US$ 286.05 million in 2022 and is expected to reach US$ 606.63 million by 2030; it is estimated to register a CAGR of 9.9% from 2022 to 2030.

Strategic Initiatives by Market Players Fuel South & Central America Prefilled Syringe Market

Various market players focus on product launches or strategic collaborations for the development of advanced products that help in the treatment of chronic disorders with ease. There have been various recent developments, such as product launches, mergers, and acquisitions in recent years. A few of them are mentioned below:
In April 2023, Delta Med Group partnered with DBM, a leading manufacturer of prefilled syringes. Delta Med Group and DBM will expand their portfolio, profiting from highly complementary products and R&D capabilities, improving their ability to serve customers. The partnership will generate significant synergies and boost the growth trajectory of the combined entity. In March 2021, SK bioscience launched a new shingles vaccine called ´SKYZoster® Ini.' The newly introduced prefilled syringe type SKYZoster can be administered more conveniently than the current intramuscular injection type in which water for injection and freeze-dried vaccine are mixed and then transferred back into the syringe. Thus, a surge in product launches and strategic collaborations is likely to create considerable growth opportunities for the prefilled syringes market in the future.

South & Central America Prefilled Syringe Market Overview

The prefilled syringes market in South & Central America is segmented into Brazil, Argentina, and the Rest of South & Central America. The prefilled syringes market is driven by increasing incidences of diabetes and infertility, and other chronic disorders followed by product development activities undertaken by major market players.

According to the International Diabetes Federation (IDF), in 2021, ~16.0 million people are living with diabetes with the prevalence rate of 10.5% and the number is expected to increase by 55% by 2045. ~90% of all diabetes diagnosed are type 2 diabetes. Further, according to the IDF, the group of children and adolescents in Brazil (age 0-14) rank third in the global panorama of type 1 diabetes, with 55,500 cases reported in 2022.

Additionally, increasing product launches for treating chronic disorders is expected to support the overall market growth in the country. In August 2021, PTC Therapeutics, Inc. ANVISA (Agência Nacional de Vigilância Sanitária) approved Waylivra (volanesorsen) as the first treatment for familial chylomicronemia syndrome (FCS) in Brazil. FCS is a rare genetic disease that results in significant disease burden to patients including potentially fatal pancreatitis and chronic complications due to permanent organ damage. Therefore, all the above factors are expected to drive the growth of prefilled syringes market.

South & Central America Prefilled Syringe Market Segmentation

The South & Central America prefilled syringe market is segmented based on type, material, design, application, distribution channel, and country.

Based on type, the South & Central America prefilled syringe market is bifurcated into disposable prefilled syringes and reusable prefilled syringes. The disposable prefilled syringes segment held a larger South & Central America prefilled syringe market share in 2022.

In terms of material, the South & Central America prefilled syringe market is bifurcated into glass prefilled syringes and plastic prefilled syringes. The glass prefilled syringes segment held a larger South & Central America prefilled syringe share in 2022.

Based on designs, the South & Central America prefilled syringe market is bifurcated into single chamber and multi chamber. The single chamber segment held a larger South & Central America prefilled syringe share in 2022.

In terms of application, the South & Central America prefilled syringe market is segmented into cancer, diabetes, autoimmune disease, infectious diseases, and others. The others segment held the largest South & Central America prefilled syringe share in 2022.

By distribution channel, the South & Central America prefilled syringe market is segmented into hospital pharmacy, retail pharmacy, and online channel. The hospital pharmacy segment held the largest South & Central America prefilled syringe market share in 2022.

Based on country, the South & Central America prefilled syringe market is categorized into Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the South & Central America prefilled syringe market in 2022.

B Braun Se, Baxter International Inc, Becton Dickinson and Co, Gerresheimer Ag, Schott Ag, Shandong Weigao Group Medical Polymer Co Ltd, and Ypsomed Holding Ag are some of the leading companies operating in the South & Central America prefilled syringe market.